Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes.
Document Type
Journal Article
Publication Date
6-1-2018
Journal
Steroids
Volume
134
Inclusive Pages
43-52
DOI
10.1016/j.steroids.2018.02.010
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
APA Citation
Hoffman, E., Riddle, V., Siegler, M., Dickerson, D., Backonja, M., Kramer, W., Nagaraju, K., Gordish-Dressman, H., Damsker, J., & McCall, J. (2018). Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes.. Steroids, 134 (). http://dx.doi.org/10.1016/j.steroids.2018.02.010
Peer Reviewed
1
Open Access
1
- Citations
- Citation Indexes: 55
- Usage
- Abstract Views: 32
- Captures
- Readers: 103
- Mentions
- References: 1
